These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 19327783)

  • 81. Effect of radiation on age at menopause among atomic bomb survivors.
    Sakata R; Shimizu Y; Soda M; Yamada M; Hsu WL; Hayashi M; Ozasa K
    Radiat Res; 2011 Dec; 176(6):787-95. PubMed ID: 21988524
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Medical Radiation Exposure among Atomic Bomb Survivors: Understanding its Impact on Risk Estimates of Atomic Bomb Radiation.
    Sadakane A; Landes RD; Sakata R; Nagano J; Shore RE; Ozasa K
    Radiat Res; 2019 Jun; 191(6):507-517. PubMed ID: 30925137
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Dose survival of G0 lymphocytes irradiated in vitro: a test for a possible population bias in the cohort of atomic bomb survivors exposed to high doses.
    Nakamura N; Sposto R; Akiyama M
    Radiat Res; 1993 Jun; 134(3):316-22. PubMed ID: 8316624
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Mental health conditions among atomic bomb survivors in Nagasaki.
    Honda S; Shibata Y; Mine M; Imamura Y; Tagawa M; Nakane Y; Tomonaga M
    Psychiatry Clin Neurosci; 2002 Oct; 56(5):575-83. PubMed ID: 12193250
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Depression and frontal dysfunction: risks for the elderly?].
    Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
    Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A dose-dependent decrease in the fraction of cases harboring M6P/IGF2R mutations in hepatocellular carcinomas from the atomic bomb survivors.
    Iwamoto KS; Yano S; Barber CL; MacPhee DG; Tokuoka S
    Radiat Res; 2006 Dec; 166(6):870-6. PubMed ID: 17149973
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Radiation-associated urinary bladder cancer.
    Hall P
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):85-8. PubMed ID: 18815921
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Estimating the incidence of dementia: the impact of adjusting for subject attrition using health care utilization data.
    Tyas SL; Tate RB; Wooldrage K; Manfreda J; Strain LA
    Ann Epidemiol; 2006 Jun; 16(6):477-84. PubMed ID: 16275012
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Risk of second malignant neoplasms among childhood cancer survivors treated with radiotherapy: meta-analysis of nine epidemiological studies.
    Doi K; Mieno MN; Shimada Y; Yoshinaga S
    Paediatr Perinat Epidemiol; 2009 Jul; 23(4):370-9. PubMed ID: 19523084
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Serum androgen levels and their association to depression and Alzheimer dementia in a cohort of 75-year-old men over 5 years: results of the VITA study.
    Ponholzer A; Madersbacher S; Rauchenwald M; Jungwirth S; Fischer P; Tragl KH
    Int J Impot Res; 2009; 21(3):187-91. PubMed ID: 19404273
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Radiation-related risks of non-cancer outcomes in the atomic bomb survivors.
    Ozasa K; Takahashi I; Grant EJ
    Ann ICRP; 2016 Jun; 45(1 Suppl):253-61. PubMed ID: 26956675
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Longitudinal trends of total white blood cell and differential white blood cell counts of atomic bomb survivors.
    Hsu WL; Tatsukawa Y; Neriishi K; Yamada M; Cologne J; Fujiwara S
    J Radiat Res; 2010; 51(4):431-9. PubMed ID: 20543527
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Lung cancer susceptibility among atomic bomb survivors in relation to CA repeat number polymorphism of epidermal growth factor receptor gene and radiation dose.
    Yoshida K; Nakachi K; Imai K; Cologne JB; Niwa Y; Kusunoki Y; Hayashi T
    Carcinogenesis; 2009 Dec; 30(12):2037-41. PubMed ID: 19843645
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Improved estimates of cancer site-specific risks for A-bomb survivors.
    Pawel D; Preston D; Pierce D; Cologne J
    Radiat Res; 2008 Jan; 169(1):87-98. PubMed ID: 18159958
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Predicting future excess events in risk assessment.
    Furukawa K; Cologne JB; Shimizu Y; Ross NP
    Risk Anal; 2009 Jun; 29(6):885-99. PubMed ID: 19187483
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Long-term effects of radiation dose on inflammatory markers in atomic bomb survivors.
    Hayashi T; Morishita Y; Kubo Y; Kusunoki Y; Hayashi I; Kasagi F; Hakoda M; Kyoizumi S; Nakachi K
    Am J Med; 2005 Jan; 118(1):83-6. PubMed ID: 15639214
    [No Abstract]   [Full Text] [Related]  

  • 97. Clonally expanded T lymphocytes from atomic bomb survivors in vitro show no evidence of cytogenetic instability.
    Hamasaki K; Kusunoki Y; Nakashima E; Takahashi N; Nakachi K; Nakamura N; Kodama Y
    Radiat Res; 2009 Aug; 172(2):234-43. PubMed ID: 19630528
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Occupational radiation exposure: population studies.
    Schleipman AR
    Radiol Technol; 2005; 76(3):185-91. PubMed ID: 15732889
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Clinical and epidemiologic characteristics of first primary tumors of the central nervous system and related organs among atomic bomb survivors in Hiroshima and Nagasaki, 1958-1995.
    Yonehara S; Brenner AV; Kishikawa M; Inskip PD; Preston DL; Ron E; Mabuchi K; Tokuoka S
    Cancer; 2004 Oct; 101(7):1644-54. PubMed ID: 15378499
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Radiation cataractogenesis: a review of recent studies.
    Ainsbury EA; Bouffler SD; Dörr W; Graw J; Muirhead CR; Edwards AA; Cooper J
    Radiat Res; 2009 Jul; 172(1):1-9. PubMed ID: 19580502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.